FDA Inspection 918373 — Zhejiang Xianju Junye Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Xianju Junye Pharmaceutical Co., Ltd. on February 13, 2015 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 13, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)